NVSNYSEManufacturing

Novartis AG (NVS) earnings date, market-implied expected move, and options open interest by expiry

160.72

pre 161.01 +0.13%

Pre-market09:00 ET

Open162.59Volume3.2MMkt cap$306.8BP/E22.33EPS7.21Div yield2.95%

Day160.72 – 163.4011%52-wk118.97 – 165.4690%

NVS

Novartis AG

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

News

25dNovartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
26dNovartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026
31dAbogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

News

Next report

Last report

+1.98%

vs ±4.9% implied · ×0.40

shaded = implied · ▲▼ = realized

Oct 27 '26 · confirmed

Implied vs realized

Linked news

3dREGN · supplierRegeneron reports Q3 net income $1,948.7 million, revenues $5,115.8 million
3dIOVA · customerIovance posts 24.6% ORR in 69 non-squamous mNSCLC patients, launches POSITILITY
3dBBIO · customerBridgeBio posts net loss of $372,969 thousand for nine months; revenue $791,362 thousand

News

Largest filed tie

13F top-10 QoQ

−4.63%

shares held · 10 largest managers

13F · Jun 30 '26125d lag

1,633 managers

Top fund weight

1.17%

NVS weight · SEIE

N-PORTJun 30 '26

2 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Novartis (NVS).

Implied vs realized

1 report

—≥ implied

Oct 27 '26Oct 27 '26confirmed±4.9%▲+1.98%×0.40

quarterimplied−5%0+5%realized×

Oct '26±4.9%▲+1.98%×0.40

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 23 close

2.86OI · 4 expiries · Oct 23 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

21,937+107%Nov 2018d7,671+32%

9,757+2%Dec 1846d1.785,474+2%1.78

33,8270%Jan 1574d3.3610,078+7%3.36

1,466—Apr 16165d2.46597—2.46

ExpiryPutsCallsP/C

Nov 2018d21,937+107%7,671+32%2.86

Dec 1846d9,757+2%5,474+2%1.78

Jan 1574d33,8270%10,078+7%3.36

Apr 16165d1,466—597—2.46

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:30 ET

Intraday

Event sensitivity

PPI ×1.56· ±1.5% vs ±1.0% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±1.5%5 of 10×1.56

FOMCrate decision±1.0%10 of 24×1.09

GDPgross domestic product±1.0%10 of 19×1.09

CPROFcorporate profits±1.0%7 of 12×1.05

NFPjobs report±1.0%6 of 10×1.04

PCEpersonal income & outlays±1.0%9 of 19×1.02

CPIconsumer prices±0.9%3 of 10×0.96

Bar = avg |move| to ±2% · tick = ±1.0% avg day · ×base = |move| ÷ ±1.0% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod